Evaluating the Controlled Release Properties of Inhaled Nanoparticles Using Isolated, Perfused, and Ventilated Lung Models (Q58691546)

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Pulmonary drug delivery systems: recent developments and prospects

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Fundamentals of pulmonary drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Inhaled prostanoids in the therapy of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Pulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Sustained release drug delivery to the lungs: an option for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

New methods of drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Moving smaller in drug discovery and delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Impact of nanotechnology on drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Biodegradable polymeric nanoparticles as drug delivery devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Biodegradable nanoparticles for drug and gene delivery to cells and tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Role of nanotechnology in targeted drug delivery and imaging: a concise review

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

The nanoscale in pulmonary delivery. Part 2: formulation platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Targeted delivery of nanoparticles for the treatment of lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Biodegradable polymeric nanocarriers for pulmonary drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Methods for the preparation and manufacture of polymeric nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Polymer-based nanocapsules for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Biodegradation and biocompatibility of PLA and PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

PLGA nanoparticles in drug delivery: the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Synthesis and characterization of PLGA nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Preclinical models for pulmonary drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Nanoparticles--a historical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Protein nanoparticles as drug carriers in clinical medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Inhalative nanomedicine--opportunities and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Nanodelivery in airway diseases: challenges and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Human respiratory epithelial cell culture for drug delivery applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Airway mucus: the good, the bad, the sticky

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

The pulmonary surfactant system: biochemical and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Pulmonary surfactant: functions and molecular composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

The role of lipids in pulmonary surfactant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Interfacial properties of pulmonary surfactant layers

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Alveolar epithelial type II cell: defender of the alveolus revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Caveolae as potential macromolecule trafficking compartments within alveolar epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Mechanisms, measurement, and significance of lung macrophage function

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Receptors for unopsonized particles: the role of alveolar macrophage scavenger receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Nanoparticles for drug delivery to the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Inhaled nanoparticles--a current review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Nanoparticle formulations in pulmonary drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

The uptake and intracellular fate of PLGA nanoparticles in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Drug delivery via the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

The lung as a route for systemic delivery of therapeutic proteins and peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Clinical perspectives on pulmonary systemic and macromolecular delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Inhaling medicines: delivering drugs to the body through the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Drugs used in the treatment of asthma: a review of clinical pharmacology and aerosol drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Inhaled corticosteroids in the long-term management of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Aerosolized vasodilators in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Inhaled iloprost for severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Medical Aerosol Inhalers: Past, Present, and Future

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

The ascent of pulmonary drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

A review of the technical aspects of drug nebulization

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Pulmonary applications and toxicity of engineered nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Clinical toxicities of nanocarrier systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Micro- and nanotechnologies for intelligent and responsive biomaterial-based medical systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

The role of branched polyesters and their modifications in the development of modern drug delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(D,L-lactide-co-glycolide): effects of polymer structure on in vitro degradation behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(d,l-lactide-co-glycolide): effects of polymer structure on cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

New polymeric carriers for controlled drug delivery following inhalation or injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Assessment methods of inhaled aerosols: technical aspects and applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Solid lipid nanoparticles for pulmonary delivery of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

The influence of fluid physicochemical properties on vibrating-mesh nebulization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Particle engineering for pulmonary drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Spray-dried powders for pulmonary drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Freeze-drying of nanoparticles: formulation, process and storage considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Preparation of redispersible dry nanocapsules by means of spray-drying: development and characterisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Formulation strategy and use of excipients in pulmonary drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Effervescent dry powder for respiratory drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Biodegradable nanoparticle flocculates for dry powder aerosol formulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Poly(D,L-lactide-co-glycolide) nanoparticle agglomerates as carriers in dry powder aerosol formulation of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Cell culture models of the respiratory tract relevant to pulmonary drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

In vivo animal models for drug delivery across the lung mucosal barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Animal models and their limitations: on the problem of high-to-low dose extrapolations following inhalation exposures

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Isolated perfused rabbit lung: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

The isolated perfused lung — A critical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

The isolated perfused lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Solute absorption from the airways of the isolated rat lung. I. The use of absorption data to quantify drug dissolution or release in the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Solute absorption from the airways of the isolated rat lung. II. Effect of surfactants on absorption of fluorescein

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Solute absorption from the airways of the isolated rat lung. III. Absorption of several peptidase-resistant, synthetic polypeptides: poly-(2-hydroxyethyl)-aspartamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Solute absorption from the airways of the isolated rat lung. IV. Mechanisms of absorption of fluorophore-labeled poly-alpha,beta-[N(2-hydroxyethyl)-DL-aspartamide].

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Solute absorption from the airways of the isolated rat lung. V. Charge effects on the absorption of copolymers of N(2-hydroxyethyl)-DL-aspartamide with DL-aspartic acid or dimethylaminopropyl-DL-aspartamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Solute disposition in the rat lung in vivo and in vitro: determining regional absorption kinetics in the presence of mucociliary escalator

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Biochemical evidence for transcytotic absorption of polyaspartamide from the rat lung: effects of temperature and metabolic inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

The pharmacokinetics of pulmonary insulin in the in vitro isolated perfused rat lung: implications of metabolism and regional deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Insulin self-association: effects on lung disposition kinetics in the airways of the isolated perfused rat lung (IPRL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Short inhalation exposures of the isolated and perfused rat lung to respirable dry particle aerosols; the detailed pharmacokinetics of budesonide, formoterol, and terbutaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Drug absorption from the isolated perfused rat lung--correlations with drug physicochemical properties and epithelial permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

High airway-to-blood transport of an opioid tetrapeptide in the isolated rat lung after aerosol delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Pulmonary absorption of aerosolized fluorescent markers in the isolated rabbit lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Comparison of pharmacokinetics and vasodilatory effect of nebulized and infused iloprost in experimental pulmonary hypertension: rapid tolerance development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Pulmonary targeting with biodegradable salbutamol-loaded nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Isolated perfused rabbit lung as a model for intravascular and intrabronchial administration of bronchodilator drugs II:Isoproterenol prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Miniaturized nebulization catheters: a new approach for delivery of defined aerosol doses to the rat lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Aerosol delivery during mechanical ventilation to the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Optimized aerosol delivery to a mechanically ventilated rodent

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Lung mechanics of the guinea-pig isolated perfused lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Measuring the weight of the isolated perfused rat lung during negative pressure ventilation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Influence of perfusate composition on drug disposition in the in-situ perfused rat lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Effect of polystyrene particles on lung microvascular permeability in isolated perfused rabbit lungs: role of size and surface properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Evaluation of particle translocation across the alveolo-capillary barrier in isolated perfused rabbit lung model

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Drug permeability in 16HBE14o- airway cell layers correlates with absorption from the isolated perfused rat lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791

Nanomedicine for respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2011%2F163791